Inflammatory signature of symptomatic CSF HIV escape unveiled by visual and quantitative MRI
Symptomatic cerebrospinal fluid (CSF) HIV escape (CSF-ESC) is an infrequent but severe condition in persons with HIV on antiretroviral therapy, defined by selective intrathecal HIV replication despite systemic suppression, and associated with a lymphoid-driven inflammatory process. We applied a quantitative MRI pipeline to standard sequences to characterize CSF-ESC in comparison to HIV encephalopathy (HIV-E) in persons not receiving combination antiretroviral therapy (cART), and neuro-asymptomatic controls. MRI scans from people with CSF-ESC (n = 12) or HIV-E (n = 10), and from neuro-asymptomatic persons with HIV (n = 11) or without HIV (n = 12) were retrospectively visually reviewed and analysed using a semi-automated pipeline. Quantitative measures included fluid-attenuated inversion recovery (FLAIR) signal intensity and apparent diffusion coefficient (ADC) from diffusion-weighted MRI, and normalized brain volumes from T1-weighted MRI. Findings were compared across groups and correlated with viro-immunological parameters. Qualitative assessment revealed white matter (WM) FLAIR hyperintensity in all CSF-ESC and HIV-E participants. Inflammatory oedema was more prevalent in CSF-ESC (7/12, with mass effect in 5), while cortical atrophy predominated in HIV-E (10/10 vs 7/12 in CSF-ESC; p = 0.005). No signal alterations or atrophy were observed in the neuroasymptomatic groups. Quantitative analyses confirmed significantly higher WM FLAIR signal and ADC in both CSF-ESC and HIV-E versus controls (all p < 0.001). Normalized WM volumes were higher in CSF-ESC, consistent with oedema, whereas both WM and grey matter (GM) volumes were lower in HIV-E (p < 0.001 and p = 0.009), indicative of atrophy. In CSF-ESC, lower nadir CD4+ cell counts, reflecting a history of prolonged immunosuppression, but not current CD4+ counts, correlated with higher GM ADC values (ρ = -0.68, p = 0.035) and lower GM volumes (ρ = 0.63, p = 0.044), consistent with cortical atrophy. Multimodal MRI adds radiological evidence to prior data supporting a pathological process in CSF-ESC that is primarily driven by active neuroinflammation, and is distinct from the low-inflammatory, atrophic profile of HIV-E. In addition, inflammation appears to superimpose on cortical atrophy in some CSF-ESC cases with a history of untreated infection. From a practical perspective, this multimodal approach may offer a valuable tool for both clinical practice and research.
Authors
- Giulio Pezzetti (ORCID: https://orcid.org/0009-0006-6057-9685)
- Simonetta Gerevini (ORCID: https://orcid.org/0000-0002-2374-194X)
- Serena Capelli (ORCID: https://orcid.org/0000-0002-8450-3806)
- Anna Caroli (ORCID: https://orcid.org/0000-0002-4130-4663)
- Riccardo Vercesi
- Francesca Ferretti (ORCID: https://orcid.org/0000-0002-6445-0954)
- Paola Maria Cinque (ORCID: https://orcid.org/0000-0003-2448-5957)
Institutions
- Vita-Salute San Raffaele University (IT)
- Mario Negri Institute for Pharmacological Research (IT)
- Ospedale Papa Giovanni XXIII (IT)
- Lewisham and Greenwich NHS Trust (GB)
Publication Details
- Journal
- Brain Communications
- Published
- 2026-11-21
- DOI
- https://doi.org/10.1093/braincomms/fcag453
- Primary Topic
- HIV Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00